Skip to content
Screener

Jasper Therapeutics, Inc. JSPR Q2 2026 earnings

Reported August 14, 2026 · Before market open

EPS-$0.10Beat by $0.17
EPS estimate-$0.27

Next report

Nov 9, 2026 (In 1 week)
Revenue estimate$6.0M
EPS estimate-$0.06

FAQ

When did Jasper Therapeutics, Inc. report Q2 2026 earnings?
Jasper Therapeutics, Inc. (JSPR) reported Q2 2026 earnings on August 14, 2026 before market open.
What were Jasper Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Jasper Therapeutics, Inc. reported eps of $-0.10 for Q2 2026.
Did Jasper Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.27 by $0.17.
How did Jasper Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 94.3% from $-1.74.
Where can I find Jasper Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-090055) and the 10-Q periodic report (0001213900-26-089592) directly on SEC EDGAR. The filing index links above go to sec.gov.